DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

FDA clears IsoRay's and GT's cesium-131 based brachytherapy Performed during surgery to remove brain tumor, reduces follow-ups

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Andrew J. Evans and Erik P. Sulman NYU Langone Health hires nationally renowned radiation oncologists

RaySearch releases RayStation 8A Offers greater support for radiation, proton and carbon ion therapies

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

Radiotherapy IT company CruxQS acquires RDS Will expand footprint for FlowBoard workflow management system

New model boosts flow efficiency of particle accelerators May lead to smaller accelerators, easier to operate at reduced costs

Why are breast cancer survivors foregoing recommended screening? Study finds poor adherence to annual mammogram guidelines

Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon? Best Particle Therapy plans to bring smaller footprint system to market in two to three years

Researchers develop AI approach for high-risk clinical tumor volumes Assisting low- and middle-income countries that lack contouring expertise

RaySearch will add boron neutron
capture therapy to its portfolio of
treatment modalities through a new
agreement with Neutron Therapeutics

RaySearch enters boron neutron capture therapy field

by John R. Fischer , Staff Reporter
A new alliance has launched RaySearch Laboratories into the field of boron neutron capture therapy (BNCT), a form of radiation treatment that targets cancer at the cellular level.

The Swedish company has partnered with Neutron Therapeutics Inc., a Massachusetts-based company, in a deal that will add BNCT to the RaySearch portfolio of treatment modalities, while applying its technology to a complete single-room solution that utilizes BNCT and is currently being developed by Neutron Therapeutics.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“This partnership is really a response to the fact that BNCT is moving toward broader adoption,” Noah Smick, vice president of business development for Neutron Therapeutics, told HCB News. “There are a number of efforts across the globe aimed at implementing BNCT in hospital environments and generating more definitive clinical data. In our experience, the demand for BNCT today outstrips the supply.”

The use of BNCT is a two-step process that starts out with the injection of a tumor-localizing drug that contains the non-radioactive isotope boron-10. A beam of low-energy neutrons is then applied to the target area with many of the neutrons absorbed by the boron-10. The absorption sets off a reaction in which short-range, high-energy charged particles are emitted to systematically destroy the tumor while minimizing damage to surrounding healthy tissue.

The agreement will extend the functionality of RayStation, which integrates all advanced treatment planning solutions offered by RaySearch into a treatment planning system, to support BNCT planning requirements and add BNCT to the range of treatments offered by RaySearch. These include photon, electron, proton and carbon ion therapy. BNCT users will have access to all advanced functionality features offered by RayStation, including atlas-based segmentation, deformable image registration, and scripting.

The complete single-room solution will include an accelerator-based neutron source, a robotic patient-physician system and a dose engine interfaced to a RayStation treatment planning system (TPS).

Smick says the partnership provides its customers with not only supportive features in the use of BNCT but also ones from an experienced and trustworthy provider.

“RaySearch is widely regarded as the world's leading platform-independent treatment planning system provider,” he said. “The primary benefit to our customers will be the ability to use a TPS for BNCT that they already know and trust. RaySearch has a successful track record of embracing powerful new radiotherapy techniques as they become available. Neutron Therapeutics is pleased that RaySearch has elected to invest in this partnership.”

The first of Neutron Therapeutics’ complete single-room BNCT solutions will be shipped in February to Helsinki University Hospital, with plans for it to be used for clinical purposes starting in 2018.

RaySearch did not respond for comment.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED